Homepage | Heart
Heart. is an international journal from BMJ and BCS publishing important research and reviews in cardiovascular disease. Heart is an international peer reviewed journal that keeps cardiologists up to date with important research advances in cardiovascular disease. New scientific developments are highlighted in editorials and put in context with ...
Treating iron deficiency in patients with heart failure: what, why ...
Introduction. Iron deficiency and anaemia, alone or in combination, are common in patients with heart failure and associated with increased risk of cardiovascular hospitalisation and death.1–3 The WHO4 defines anaemia as a haemoglobin <120 g/L for women and <130 g/L for men. Recent data suggest that even borderline anaemia (ie, 10 g/L above the WHO threshold) is associated with an increase ...
Bradyarrhythmias in patients with atrial fibrillation | Heart
The increasing burden of atrial fibrillation (AF) and significant morbidity/mortality associated with this arrhythmia encourage screening it in clinical practice, as recommended in current guidelines. It means opportunistic screening (in patients over 65 years) or systematic screening (in people above 75 years) by using clinical examination, followed by an ECG, 24-hour ECG monitoring or ...
Calcium and vitamin D supplement: right or wrong? - Heart
Intuitively, one might think that supplementing vitamins and minerals would be the right thing to do especially in older and comorbid people. Every year, billions of dollars are spent in this belief.1 However, we may all be wrong. A present study in this journal demonstrates a significantly increased cardiovascular (CV) mortality in elderly patients supplementing calcium, be it …
Lifetime effects and cost-effectiveness of statin therapy for older ...
Background Cardiovascular disease (CVD) risk increases with age. Statins reduce cardiovascular risk but their effects are less certain at older ages. We assessed the long-term effects and cost-effectiveness of statin therapy for older people in the contemporary UK …
Advancing the access to cardiovascular diagnosis and treatment …
Despite significant progress in cardiovascular pharmacotherapy and interventional strategies, cardiovascular disease (CVD), in particular ischaemic heart disease, remains the leading cause of morbidity and mortality among women in the UK and worldwide. Women are underdiagnosed, undertreated and under-represented in clinical trials directed at management strategies for CVD, making their results ...
History and evolution of pacing and devices | Heart
Cardiac implanted electronic devices are commonplace in the modern practice of cardiology. This article reviews the history of the development of these technologies, with particular reference to the role played by UK physicians and members of the British Cardiovascular Society. Key breakthroughs in the treatment of heart block, ventricular arrhythmia and heart failure are presented in their ...
Prevalence, incidence and survival of heart failure: a systematic ...
Studies of the epidemiology of heart failure in the general population can inform assessments of disease burden, research, public health policy and health system care delivery. We performed a systematic review of prevalence, incidence and survival for all available population-representative studies to inform the Global Burden of Disease 2020. …
Basics of cardiac pacing: selection and mode choice | Heart
Therapeutic cardiac stimulation has been in clinical practice for many decades.1 During the evolution of the therapy, pacing generators have shrunk in size, increased in longevity, and increased in device complexity. They offer rhythm and disease state diagnostics, with various algorithms designed to offer timing of delivery of pacing impulse and …
The role of COVID-19 vaccines in preventing post-COVID-19
Objective To study the association between COVID-19 vaccination and the risk of post-COVID-19 cardiac and thromboembolic complications. Methods We conducted a staggered cohort study based on national vaccination campaigns using electronic health records from the UK, Spain and Estonia. Vaccine rollout was grouped into four stages with predefined enrolment periods. Each stage included all ...